Cholesteryl ester transfer activity in plasma of patients with familial high-density lipoprotein deficiency.

We determined cholesteryl ester transfer activity in whole plasma and in lipoprotein-depleted plasma of normolipidemic subjects and of patients with severe high-density lipoprotein (HDL) deficiency: Tangier disease, lecithin:cholesterol acyltransferase (LCAT) deficiency, and "fish-eye" disease. Transfer rates in plasma were positively correlated (r = 0.950) with rates measured in the absence of the endogenous lipoproteins. This suggests that lipoprotein composition and content may not affect total cholesteryl ester transfer activity in normolipidemic and the HDL-deficient subjects. Cholesteryl ester transfer from solid-phase-bound HDL to plasma lipoproteins was decreased by 39% in fish-eye disease and 33% in LCAT deficiency but increased by 57% in Tangier disease, as compared with normal values. Changes were similar for lipoprotein-depleted plasma from the same individuals. Transfer to plasma HDL was significantly decreased in all HDL-deficient patients, whereas transfer to very-low- and low-density lipoproteins was increased only in Tangier disease. Differences in transfer rates between the patients studied appeared to reflect the LCAT activity and the need to transport cholesteryl ester rather than the HDL cholesterol concentration. Thus, the concentration of HDL in plasma does not directly affect total cholesteryl ester transfer activity in HDL deficiency.

[1]  J. Frohlich,et al.  Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease). , 1988, Biochimica et biophysica acta.

[2]  M. Hayden,et al.  Hypoalphalipoproteinemia resembling fish eye disease. , 2009, Acta medica Scandinavica.

[3]  J. Frohlich,et al.  Study of the components of reverse cholesterol transport in lecithin:cholesterol acyltransferase deficiency. , 1987, Archives of biochemistry and biophysics.

[4]  J. Frohlich,et al.  Cholesteryl ester transfer activity in plasma measured by using solid-phase-bound high-density lipoprotein. , 1987, Clinical chemistry.

[5]  J. Groener,et al.  A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity. , 1987, The Biochemical journal.

[6]  A. Tall Plasma lipid transfer proteins. , 1986, Journal of lipid research.

[7]  S. Yokoyama,et al.  Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia. , 1985, Journal of biochemistry.

[8]  E. Schaefer Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. , 1984, Arteriosclerosis.

[9]  D. B. Zilversmit,et al.  Comparison of various methods for in vitro cholesteryl ester labeling of lipoproteins from hypercholesterolemic rabbits. , 1984, Biochimica et biophysica acta.

[10]  J. Albers,et al.  Isolation and Characterization of Human Plasma Lipid Transfer Proteins , 1984, Arteriosclerosis.

[11]  G. L. Mills,et al.  A guidebook to lipoprotein technique , 1984 .

[12]  L. Carlson,et al.  Plasma lipid transfer in fish-eye disease. , 2009, Acta medica Scandinavica.

[13]  D. B. Zilversmit,et al.  A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. , 1981, The Journal of biological chemistry.

[14]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[15]  G Bucolo,et al.  Quantitative determination of serum triglycerides by the use of enzymes. , 1973, Clinical chemistry.

[16]  E. Korn,et al.  Single bilayer liposomes prepared without sonication. , 1973, Biochimica et biophysica acta.